About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Contact the Docs

Docs on Twitter


Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Monsanto Announces Latest Lawsuit Settlement over Roundup Ready® Soybean Seed | Main | USPTO News: USPTO and UKIPO Extend Patent Prosecution Highway Pilot Program »

September 02, 2008

Comments

It's September 24. Is there any sign of the GSK/Tafas reply brief?

T:

Nothing yet, but it's still early in the day. We will check again later today.

Don

Were the briefs filed yesterday?

Anon:

Yes, GSK filed its brief yesterday (although the CAFC did not list the brief as filed until this morning). However, because CAFC briefs are not available via PACER and GSK has not released its brief to the public, we have not had a chance to review it yet.

Don

The comments to this entry are closed.

July 2020

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31